Agios Pharmaceuticals Lands $33,000,000 Series A Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=13e2d2d7-5d74-489f-aeb4-a168957eac5f&Preview=1 -
Date
7/7/2008 -
Company Name
Agios Pharmaceuticals -
Mailing Address
29 Newbury Street Boston, MA 02116 -
Company Description
Agios is a biopharmaceutical company at the forefront of one of the most exciting new areas of cancer research: cancer metabolism. Cancer metabolism represents a breakthrough understanding of how cancer cells become addicted to using more nutrients than normal cells to ensure their survival and growth. -
Website
http://www.agios.com -
Transaction Type
Venture Equity -
Transaction Amount
$33,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Third Rock Ventures -
Venture Investor
Flagship Ventures -
Venture Investor
ARCH Venture Partners
